Sanara MedTech Change in Accounts Payable 2014-2025 | SMTI

Sanara MedTech change in accounts payable from 2014 to 2025. Change in accounts payable can be defined as the increase or decrease in trade payables for the given period.

Sanara MedTech Change in Accounts Payable 2014-2025 | SMTI

Sanara MedTech change in accounts payable from 2014 to 2025. Change in accounts payable can be defined as the increase or decrease in trade payables for the given period.
Related Stocks
Company NameMarket
Cap
Abbott Laboratories (ABT)$230.5B
Boston Scientific (BSX)$157.1B
Stryker (SYK)$149.8B
EssilorLuxottica (ESLOY)$148.8B
Medtronic (MDT)$119.5B
Lonza Group Ag (LZAGY)$50.1B
Haleon (HLN)$44.5B
ResMed (RMD)$42.3B
Agilent Technologies (A)$33.8B
GE HealthCare Technologies (GEHC)$33.7B
Terumo (TRUMY)$27.7B
Koninklijke Philips (PHG)$26.7B
Insulet (PODD)$23.4B
Zimmer Biomet Holdings (ZBH)$20.9B
Smith & Nephew SNATS (SNN)$16.4B
Baxter (BAX)$12.5B
Sunny Optical Technology (SNPTF)$10.8B
Demant (WILYY)$8.1B
Bio-Rad Laboratories (BIO)$7.8B
Lantheus Holdings (LNTH)$3.8B
Shandong Weigao Medical Polymer (SHWGF)$3.5B
Envista Holdings (NVST)$3.4B
Perrigo (PRGO)$3.3B
Prestige Consumer Healthcare (PBH)$3.2B
ICU Medical (ICUI)$3B
Haemonetics (HAE)$2.6B
LeMaitre Vascular (LMAT)$2.2B
AtriCure (ATRC)$1.8B
QuidelOrtho (QDEL)$1.8B
Curaleaf Holdings (CURLF)$1.7B